- Home
- MLYS vs NMIH Comparison
MLYS vs NMIH Comparison
Compare MLYS & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- NMIH
- Stock Information
- Founded
- MLYS 2019
- NMIH 2011
- Country
- MLYS United States
- NMIH United States
- Employees
- MLYS N/A
- NMIH N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- NMIH Property-Casualty Insurers
- Sector
- MLYS Health Care
- NMIH Finance
- Exchange
- MLYS Nasdaq
- NMIH Nasdaq
- Market Cap
- MLYS 3.1B
- NMIH 2.9B
- IPO Year
- MLYS 2023
- NMIH 2013
- Fundamental
- Price
- MLYS $38.06
- NMIH $36.72
- Analyst Decision
- MLYS Strong Buy
- NMIH Buy
- Analyst Count
- MLYS 6
- NMIH 6
- Target Price
- MLYS $42.60
- NMIH $42.33
- AVG Volume (30 Days)
- MLYS 1.6M
- NMIH 383.8K
- Earning Date
- MLYS 11-10-2025
- NMIH 11-05-2025
- Dividend Yield
- MLYS N/A
- NMIH N/A
- EPS Growth
- MLYS N/A
- NMIH 11.30
- EPS
- MLYS N/A
- NMIH 4.71
- Revenue
- MLYS N/A
- NMIH $679,621,000.00
- Revenue This Year
- MLYS N/A
- NMIH N/A
- Revenue Next Year
- MLYS N/A
- NMIH $5.15
- P/E Ratio
- MLYS N/A
- NMIH $7.80
- Revenue Growth
- MLYS N/A
- NMIH 9.99
- 52 Week Low
- MLYS $8.24
- NMIH $31.90
- 52 Week High
- MLYS $41.09
- NMIH $43.20
- Technical
- Relative Strength Index (RSI)
- MLYS 62.11
- NMIH 31.40
- Support Level
- MLYS $37.32
- NMIH $38.68
- Resistance Level
- MLYS $40.51
- NMIH $39.79
- Average True Range (ATR)
- MLYS 2.09
- NMIH 0.88
- MACD
- MLYS -0.77
- NMIH -0.28
- Stochastic Oscillator
- MLYS 43.86
- NMIH 1.60
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.